FamiCord AG (FRA:V3V)

Market Cap	91.52M
Revenue (ttm)	87.73M
Net Income (ttm)	-9.91M
Shares Out	n/a
EPS (ttm)	-0.56
PE Ratio	n/a
Forward PE	114.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,136
Average Volume	514
Open	5.10
Previous Close	5.40
Day's Range	5.10 - 5.45
52-Week Range	3.64 - 7.65
Beta	n/a
RSI	44.74
Earnings Date	Nov 21, 2025

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 771
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V3V

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.